Recombinant Human VEGF121 Protein

• Description:

  Recombinant Human VEGF121 Protein_x000D_ Catalog number: B2015594_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 5 µg_x000D_ Molecular Weight or Concentration: 37 kDa, homodimer; 50 kDa, homotrimer, glycosylated_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20¬∞C_x000D_ Keywords: L VEGFA, MVCD1, Vascular permeability factor, VEGF, VEGF A, VEGF121, VEGFA, VPF_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Abraham S, Rangaswamy SP, Chinnaiah A. Evaluation of recombinant human vascular endothelial growth factor VEGF121-loaded poly-l-lactide microparticles as a controlled release delivery system Turk J Biol. 2020 Feb 17;44(1):34-47._x000D_ 2: Kaplan O, Z√°rubov√° J, Mikulov√° B, Filov√° E, B√°rtov√° J, Baƒç√°kov√° L, Brynda E. Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones PLoS One. 2016 Oct 7;11(10):e0163697._x000D_ 3: Ciomber A, Smagur A, Mitrus I, Cicho≈Ñ T, Smolarczyk R, Sochanik A, Szala S, Jarosz M. Antitumor effects of recombinant antivascular protein ABRaA-VEGF121 combined with IL-12 gene therapy Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):161-8._x000D_ 4: Smagur A, Boyko MM, Biront NV, Cicho≈Ñ T, Szala S. Chimeric protein ABRaA-VEGF121 is cytotoxic towards VEGFR-2-expressing PAE cells and inhibits B16-F10 melanoma growth Acta Biochim Pol. 2009;56(1):115-24. Epub 2009 Feb 27._x000D_ 5: Lin JD, Chao TC. Vascular endothelial growth factor in thyroid cancers Cancer Biother Radiopharm. 2005 Dec;20(6):648-61._x000D_ 6: Mohamedali KA, Cao Y, Cheung LH, Hittelman WN, Rosenblum MG. The functionalized human serine protease granzyme B/VEGF‚ÇÅ‚ÇÇ‚ÇÅ targets tumor vasculature and ablates tumor growth Mol Cancer Ther. 2013 Oct;12(10):2055-66._x000D_ 7: Wolfson MR, Funanage VL, Kirwin SM, Pilon AL, Shashikant BN, Miller TL, Shaffer TH. Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome Am J Perinatol. 2008 Nov;25(10):637-45._x000D_ 8: Ramakrishnan S, Wild R, Nojima D. Targeting tumor vasculature using VEGF-toxin conjugates Methods Mol Biol. 2001;166:219-34._x000D_ 9: Mohamedali KA, Kedar D, Sweeney P, Kamat A, Davis DW, Eve BY, Huang S, Thorpe PE, Dinney CP, Rosenblum MG. The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors Neoplasia. 2005 Oct;7(10):912-20._x000D_ 10: George EM, Liu H, Robinson GG, Mahdi F, Perkins E, Bidwell GL 3rd. Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis Vasc Cell. 2015 Jan 24;7(1):1. _x000D_ _x000D_ Products Related to Recombinant Human VEGF121 Protein can be found at Proteins

• Short Description:

  Catalog Number: B2015594 (5 µg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• CAS Number:

  9000-83-3